Tagrisso Prices, Coupons and Patient Assistance Programs
Tagrisso (osimertinib) is a member of the EGFR inhibitors drug class and is commonly used for Non-Small Cell Lung Cancer.
Tagrisso Prices
The cost for Tagrisso oral tablet 40 mg is around $15,887 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Tagrisso is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Tagrisso availability.
This Tagrisso price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Oral Tablet
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $529.57 | $15,887.14 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $529.57 | $15,887.14 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Tagrisso Coupons and Rebates
Tagrisso offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Tagrisso Access 360 Patient Savings Program: Eligible commercially insured patients may pay $0 per 28-day supply with savings of up to $26,000 per year; for additional information contact the program at 844-275-2360.
| Applies to: | Tagrisso |
| Number of uses: | Per prescription until program expires |
Patient Assistance Programs for Tagrisso
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: AZ&Me Prescription Savings Program for people without insurance
Elligibility requirements:- Must have no prescription coverage
- Varies
- Not required
- The patient must also be a US resident.
- People who are in Medicare and may be eligible for the Limited Income Subsidy can apply. However, if they are accepted into the LIS, they are no longer eligible for the AZ& Me Prescription Savings Program. Eligibility determined on a case-by-case basis.
Applicable drugs:
- Tagrisso (osimertinib) Tablet
Provider: AZ&Me Prescription Savings Program for people with Medicare Part D
Elligibility requirements:- Contact program for details.
- Varies
- Not required
- The patient must also be a US resident.
- Eligibility determined on a case-by-case basis.
Applicable drugs:
- Tagrisso (osimertinib) Tablet
Provider: HealthWell Foundation Copay Program
Elligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
- Tagrisso (osimertinib) Tablet
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Tagrisso (osimertinib) Tablet
Provider: Access 360
Elligibility requirements:- Determined case by case
- Varies. *See below for details
- Not specified
- The patient must also be a US resident, green card or work visa holder.
- Contact program for more details: www.myaccess360.com
Applicable drugs:
- Tagrisso (osimertinib) Tablet
More about Tagrisso (osimertinib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 13 Reviews
- Drug class: EGFR inhibitors
- FDA Approval History
